Roundy's Inc. Common Stock (RNDY) 3.60 $RNDY Kroger

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Roundy's Inc. Common Stock (RNDY) 3.60 $RNDY

Kroger Completes Tender Offer of Shares of Roundy's
PR Newswire - Fri Dec 18, 7:00AM CST
The Kroger Co. (NYSE: KR) and Roundy's, Inc. (NYSE: RNDY) today announced the successful completion of Kroger's tender offer to purchase all outstanding shares of Roundy's common stock for $3.60 per share in cash. The tender offer expired at 11:59 p.m., Eastern Standard Time, on December 17, 2015.
KR: 32.67 (+0.17), RNDY: 3.60 (unch)

Where Opportunity is Found - Analyst Notes on Applied DNA Sciences, Lion Biotechnologies, LinnCo and Roundy's
ACCESSWIRE - Tue Dec 15, 6:30AM CST
NEW YORK, NY / ACCESSWIRE / December 15, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Applied DNA Sciences, Inc (NASDAQ: APDN), Lion Biotechnologies Inc (NASDAQ: LBIO), LinnCo LLC (NASDAQ: LNCO) and Roundy's Inc (NYSE: RNDY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
LNCO: 0.12 (unch), APDN: 3.20 (unch), LBIO: 8.04 (+0.07), RNDY: 3.60 (unch)

3 Best Stocks to Invest in Healthy Eating
Brian Stoffel, Asit Sharma, and Beth McKenna, The Motley Fool - Motley Fool - Mon Dec 14, 2:22PM CST
Oh how the times have changed. As a kid, my parents didn't think twice about grabbing fast food for dinner if we were in a time pinch. It was quick, easy, and pretty delicious. But that's not the world we live in anymore. As we learn more and more...
WFM: 30.70 (-0.08), WWAV: 55.74 (+0.08), HAIN: 36.82 (+0.17), AMZN: 788.87 (+16.43), UNFI: 45.80 (+0.01), KR: 32.67 (+0.17), RNDY: 3.60 (unch)

The Price Movement Tells the Story - Research on Genocea Biosciences, Roundy's, Pacific Ethanol, and JAKKS Pacific
ACCESSWIRE - Fri Nov 20, 7:45AM CST
NEW YORK, NY / ACCESSWIRE / November 20, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Genocea Biosciences Inc. (NASDAQ: GNCA), Roundy's Inc. (NYSE: RNDY), Pacific Ethanol Inc. (NASDAQ: PEIX) and JAKKS Pacific Inc. (NASDAQ: JAKK). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
JAKK: 9.10 (-0.09), GNCA: 5.43 (+0.06), PEIX: 6.63 (+0.05), RNDY: 3.60 (unch)

With Wal-Mart Stumbling, No. 2 Kroger Looks for More Share
Rich Duprey, The Motley Fool - Motley Fool - Tue Nov 17, 3:20PM CST
No. 2 grocery-store chain Kroger sees this weak moment from Wal-Mart as a chance to steal market share from the retail king.  This probably isn't the last acquisition for Kroger and certainly not the biggest, but the purchase of midwest rival ...
WFM: 30.70 (-0.08), KR: 32.67 (+0.17), SVU: 5.69 (-0.03), DEG: 28.11 (-0.02), TGT: 70.10 (-0.71), WMT: 73.00 (+0.50), DG: 72.00 (-1.32), RNDY: 3.60 (unch)

ROUNDY'S SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Roundy's, Inc. (RNDY) Over the Proposed Sale of the Company to The Kroger Co.
BusinessWire - Tue Nov 17, 11:27AM CST
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Roundy's, Inc. ("Roundy's" or the "Company" (NYSE:RNDY) for potential breaches of fiduciary duties in connection with the sale of the Company to The Kroger Co. for approximately $800 million in a cash transaction.
RNDY: 3.60 (unch)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Roundy's, Inc.
BusinessWire - Thu Nov 12, 8:35PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Roundy's, Inc. ("Roundy's" or "the Company" (NYSE: RNDY) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Kroger Co. ("Kroger".
KR: 32.67 (+0.17), RNDY: 3.60 (unch)

Lifshitz & Miller Law Firm Announces Investigation of C1 Financial, Inc., Checkpoint Systems, Inc., Diamond Foods, Inc., Freshpet, Inc., HeartWare International, Inc., Hutchinson Technology Incorporated, Roundy's, Inc., and ZS Pharma
PR Newswire - Thu Nov 12, 5:56PM CST
C1 Financial, Inc. (BNK)
DMND: 37.56 (+0.36), HTCH: 1.46 (-0.03), ZSPH: 89.98 (+0.06), FRPT: 10.50 (+0.27), BNK: 23.39 (-0.20), RNDY: 3.60 (unch), HTWR: 58.20 (+0.22), CKP: 10.14 (unch)

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Roundy's, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Thu Nov 12, 4:50PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Roundy's, Inc. (NYSE: RNDY) ("Roundy's" or the "Company" relating to the proposed buyout of the Company by The Kroger Co.
KR: 32.67 (+0.17), RNDY: 3.60 (unch)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Roundy's, Inc. of an Investigation In Connection With the Fairness of the Sale of the Company to Kroger Co. -- RNDY
ACCESSWIRE - Thu Nov 12, 11:36AM CST
NEW YORK, NY / ACCESSWIRE / November 12, 2015 / The following statement is being issued by Levi & Korsinsky, LLP:
KR: 32.67 (+0.17), RNDY: 3.60 (unch)

Company News for November 12, 2015
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 9:10AM CST
Companies in the News are: RNDY,KR,MTOR,ADT,PAH
KR: 32.67 (+0.17), PAH: 9.41 (+0.07), MTOR: 11.19 (+0.02), RNDY: 3.60 (unch), ADT: 41.98 (+0.03)

Harwood Feffer LLP Announces Investigation of Roundy's, Inc.
PR Newswire - Wed Nov 11, 2:03PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Roundy's, Inc. ("Roundy's" or the "Company" (NYSE: RNDY) concerning the proposed acquisition of the Company by Kroger Co. ("Kroger".
RNDY: 3.60 (unch)

ROUNDY'S INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Kroger Co. May be Unfair to Shareholders
BusinessWire - Wed Nov 11, 12:11PM CST
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Roundy's Inc. ("Roundy's" (NYSE: RNDY) concerning the acquisition by Kroger Co. Under the terms of the agreement, valued at approximately $800 million, Roundy's shareholders will only receive $3.60 per share owned. The consideration is significantly lower than at least one analyst's estimated value of $5.00.
RNDY: 3.60 (unch)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Roundy's, Inc. of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to Kroger Co.
BusinessWire - Wed Nov 11, 9:43AM CST
The following statement is being issued by Levi & Korsinsky, LLP:
KR: 32.67 (+0.17), RNDY: 3.60 (unch)

ROUNDY'S ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Launches an Investigation into the Proposed Sale of Roundy's. Are Roundy's Shareholders Getting a Fair Price?
BusinessWire - Wed Nov 11, 8:32AM CST
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Roundy's, Inc. (NYSE: RNDY) breached their fiduciary duties in connection with the proposed sale of the Company to The Kroger Co.
RNDY: 3.60 (unch)

Kroger and Roundy's Announce Definitive Merger Agreement
PR Newswire - Wed Nov 11, 7:31AM CST
The Kroger Co. (NYSE: KR) and Roundy's, Inc. (NYSE: RNDY) today announced a definitive merger agreement under which Kroger will purchase all outstanding shares of Roundy's for $3.60 per share in cash.
KR: 32.67 (+0.17), RNDY: 3.60 (unch)

Iconix Falls on Q3 Earnings & Sales Miss; Lowers View
Zacks Equity Research - Zacks Investment Research - Tue Nov 10, 12:10PM CST
New York-based Iconix Brand Group, Inc. (ICON) reported sluggish results, as it missed the Zacks Consensus Estimate for earnings and revenues in the third quarter of 2015.
ICON: 8.60 (+0.01), KR: 32.67 (+0.17), NKE: 57.41 (-0.61), RNDY: 3.60 (unch)

hhgregg (HGG) Q2 Loss Wider than Expected; Revenues Lag
Zacks Equity Research - Zacks Investment Research - Fri Nov 06, 9:06AM CST
hhgregg (HGG) reported wider-than-expected loss in the second quarter fiscal 2016.
KR: 32.67 (+0.17), HGG: 1.98 (-0.08), FRED: 10.78 (-0.27), RNDY: 3.60 (unch)

Companhia Brasileira de Distribuicao Q3 Income Plummets
Zacks Equity Research - Zacks Investment Research - Mon Nov 02, 9:00AM CST
Companhia Brasileira de Distribuicao Q3 Income Plummets
KR: 32.67 (+0.17), TGT: 70.10 (-0.71), RNDY: 3.60 (unch), CBD: 16.23 (+0.04)

The Zacks Analyst Blog Highlights: Wal-Mart Stores, Amazon.com, Roundy's and Kroger
Zacks Equity Research - Zacks Investment Research - Wed Oct 28, 8:30AM CDT
The Zacks Analyst Blog Highlights: Wal-Mart Stores, Amazon.com, Roundy’s and Kroger
AMZN: 788.87 (+16.43), KR: 32.67 (+0.17), WMT: 73.00 (+0.50), RNDY: 3.60 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Interim Findings from Medicus Pharma's BCC Study

Updated Category News Views 164

Positive Interim Analysis from Medicus Pharma Ltd Medicus Pharma Ltd. (NASDAQ: MDCX) has recently shared exciting interim results from its SKNJCT-003 Phase 2 clinical study, which focuses on a non-invasive approach to treat basal cell carcinoma (BCC) of the skin. This news marks a significant milestone as the company aims to revolutionize the treatment options available...

Continue Reading
DroneShield's Immediate Response Kit Wins Platinum Award for Innovation

Updated Category News Views 161

DroneShield's Immediate Response Kit Gains Recognition for Innovation DroneShield has recently been awarded the prestigious Platinum Award for Innovation by Military and Aerospace Electronics, showcasing its Immediate Response Kit (IRK) as a cornerstone in drone detection and defeat technology. This award is a testament to the exceptional capabilities of the IRK, which...

Continue Reading
Jefferies Holds ABB Rating; Analysts Assess Mixed Results

Updated Category News Views 65

Jefferies Maintains Hold Rating on ABB Stock Jefferies recently continued its Hold rating for ABB Ltd (NYSE: ABB) and set a price target of CHF50.00, following the company's third-quarter performance report. The report showcased a mixed array of results, with certain metrics outperforming expectations while others showed disappointing trends. During the third quarter, ABB...

Continue Reading
Surgical Clips Market Projected to Reach $1.8 Billion Soon

Updated Category News Views 211

Overview of the Surgical Clips Market Recent analysis of the surgical clips market reveals an impressive valuation of USD 655.9 million in 2023, with projections indicating a potential growth to USD 1.8 billion by 2032. This remarkable increase is attributed to a compound annual growth rate (CAGR) of 11.9% from 2024. Understanding Surgical Clips and Their Importance...

Continue Reading
Public Disclosure of Opening Position by Keywords Studios Plc

Updated Category News Views 74

Public Opening Position Disclosure for Keywords Studios Plc This document provides important information about a public opening position disclosure related to Keywords Studios Plc. It includes details about individuals or entities holding 1% or more of relevant securities. This disclosure is made in accordance with Rule 8.3 of the Takeover Code, which ensures that all...

Continue Reading